FGFR4 is the predominant FGFR isoform in hepatocytes, and the FGF19/FGFR4 axis promotes EMT through GSK3β phosphorylation and activation of the β-catenin/TCF4 pathway in HCC [61]. Here, GSK3B is linked to hepatocellular carcinoma.